lovastatin has been researched along with Skin Neoplasms in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, S; Lou, D; Wang, D; Wang, S; Wang, T; Zheng, Z | 1 |
| Barr, RJ; Carpenter, PM; Chen, WP; Cochran, AJ; Elmets, CA; Jakowatz, JG; Leachman, SA; Lim, SJ; Linden, KG; McLaren, CE; Meyskens, FL; Tangrea, JA; Viner, JL; Zager, JS | 1 |
| Desai, M; Hedlin, H; Kapphahn, K; Manson, JA; Martin, L; Simon, M; Stefanick, ML; Strickler, H; Tang, JY; Wactawski-Wende, J; Wang, A | 1 |
| Dellavalle, RP; Drake, AL; Freeman, SR; Graber, M; Heilig, LF; McNealy, K; Schilling, LM | 1 |
| Clynes, M; Eustace, AJ; Glynn, SA; O'Donovan, N; O'Sullivan, D | 1 |
| Agarwal, R; Bickers, DR; Khan, SG; Mukhtar, H; Saxena, R | 1 |
| Blegen, H; Carlberg, M; Dricu, A; Hjertman, M; Larsson, O; Malec, M; Wang, M; Wejde, J | 1 |
| Feleszko, W; Gołab, J; Jakóbisiak, M; Zagozdzon, R | 1 |
2 review(s) available for lovastatin and Skin Neoplasms
| Article | Year |
|---|---|
Association between statins exposure and risk of skin cancer: an updated meta-analysis.
Topics: Carcinoma, Basal Cell; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Simvastatin; Skin Neoplasms | 2023 |
Statins, fibrates, and melanoma risk: a systematic review and meta-analysis.
Topics: Atorvastatin; Bezafibrate; Clofibrate; Gemfibrozil; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Incidence; Lovastatin; Melanoma; Odds Ratio; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic; Reproducibility of Results; Simvastatin; Skin Neoplasms; United States | 2006 |
1 trial(s) available for lovastatin and Skin Neoplasms
| Article | Year |
|---|---|
A randomized, double-blind, placebo-controlled phase II clinical trial of lovastatin for various endpoints of melanoma pathobiology.
Topics: Adult; Anticholesteremic Agents; Biomarkers, Tumor; Cell Transformation, Neoplastic; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Lovastatin; Male; Melanoma; Middle Aged; Nevus; Placebos; Skin Neoplasms | 2014 |
5 other study(ies) available for lovastatin and Skin Neoplasms
| Article | Year |
|---|---|
Relation of statin use with non-melanoma skin cancer: prospective results from the Women's Health Initiative.
Topics: Age Factors; Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cohort Studies; Environmental Exposure; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Indoles; Logistic Models; Longitudinal Studies; Lovastatin; Middle Aged; Odds Ratio; Overweight; Prospective Studies; Pyridines; Risk Factors; Simvastatin; Skin Neoplasms; Smoking; Sunlight; Vitamin D; Vitamins; White People | 2016 |
The 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, simvastatin, lovastatin and mevastatin inhibit proliferation and invasion of melanoma cells.
Topics: Apoptosis; Breast Neoplasms; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Lovastatin; Lung Neoplasms; Male; Melanoma; Neoplasm Invasiveness; Simvastatin; Skin Neoplasms | 2008 |
Inhibition of ras p21 membrane localization and modulation of protein kinase C isozyme expression during regression of chemical carcinogen-induced murine skin tumors by lovastatin.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Cell Membrane; Enzyme Activation; Female; Isoenzymes; Lovastatin; Mice; Mice, Inbred SENCAR; Papilloma; Protein Kinase C; Protein Processing, Post-Translational; Proto-Oncogene Proteins p21(ras); Skin; Skin Neoplasms | 1995 |
Mevalonate-regulated mechanisms in cell growth control: role of dolichyl phosphate in expression of the insulin-like growth factor-1 receptor (IGF-1R) in comparison to Ras prenylation and expression of c-myc.
Topics: Cell Division; Cell Membrane; Colonic Neoplasms; DNA, Neoplasm; Dolichol Phosphates; Glycosylation; Humans; Kinetics; Lovastatin; Melanoma; Mevalonic Acid; Neoplasm Proteins; Polymerase Chain Reaction; Protein Prenylation; ras Proteins; Receptor, IGF Type 1; Skin Neoplasms; Tumor Cells, Cultured | 1997 |
Potentiated antitumour effects of cisplatin and lovastatin against MmB16 melanoma in mice.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Synergism; Female; Lovastatin; Melanoma, Experimental; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Skin Neoplasms | 1998 |